Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score

• Tiziano Barbui,
• Arianna Ghirardi,
• Alessandra Carobbio,
• Arianna Masciulli,
• Greta Carioli,
• Alessandro Rambaldi,
• Maria Chiara Finazzi,
• Marta Bellini,
• Elisa Rumi,
• Daniele Vanni,
• Oscar Borsani,
• Francesco Passamonti,
• Barbara Mora,
• Marco Brociner,
• Paola Guglielmelli,
• Chiara Paoli,
• Alberto Alvarez-Larran,
• Ana Triguero,
• Marta Garrote,
• Helna Pettersson,
• Björn Andréasson,
• Giovanni Barosi,
• Alessandro Maria Vannucchi

Affiliations

Tiziano Barbui

FROM Research Foundation, ASST Papa Giovanni XXIII

Arianna Ghirardi

FROM Research Foundation, ASST Papa Giovanni XXIII

Alessandra Carobbio

FROM Research Foundation, ASST Papa Giovanni XXIII

Arianna Masciulli

FROM Research Foundation, ASST Papa Giovanni XXIII

Greta Carioli

FROM Research Foundation, ASST Papa Giovanni XXIII

Alessandro Rambaldi

ASST Papa Giovanni XXIII

Maria Chiara Finazzi

ASST Papa Giovanni XXIII

Marta Bellini

ASST Papa Giovanni XXIII

Elisa Rumi

Department of Molecular medicine, University of Pavia

Daniele Vanni

Hematology, Fondazione IRCCS Policlinico San Matteo

Oscar Borsani

Hematology, Fondazione IRCCS Policlinico San Matteo

Francesco Passamonti

University of Insubria

Barbara Mora

University of Insubria

Marco Brociner

ASST Sette Laghi

Paola Guglielmelli

CRIMM, Azienda Ospedaliera Universitaria Careggi

Chiara Paoli

CRIMM, Azienda Ospedaliera Universitaria Careggi

Alberto Alvarez-Larran

Hematology Department, Hospital Clínic

Ana Triguero

Hematology Department, Hospital Clínic

Marta Garrote

Hematopathology Unit, Pathology Department, Hospital Clínic

Helna Pettersson

Division of Hematology, NU Hospital Group

Björn Andréasson

Division of Hematology, NU Hospital Group

Giovanni Barosi

Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation

Alessandro Maria Vannucchi

CRIMM, Azienda Ospedaliera Universitaria Careggi